Nutro Life Science, operating under Livo Universal Healthcare, has announced a landmark investment in India’s nutraceutical sector. The company plans to establish what it calls the world’s first fully robotic sports nutrition manufacturing facility. Currently under construction in Ludhiana, Punjab, this facility spans over one acre of land. Furthermore, the plant is expected to be operational by December 2026.
World’s First Fully Robotic Nutrition Facility
A Milestone for Indian Manufacturing
This Ludhiana plant marks a turning point in how India approaches nutraceutical production. Unlike conventional factories, the new facility uses end-to-end robotics across the entire production lifecycle. Therefore, human intervention drops significantly throughout the manufacturing process. The result is higher consistency, better hygiene, and near-zero production errors.
Moreover, India’s nutraceutical sector has grown rapidly over the past decade. However, most facilities still rely heavily on manual processes. Nutro Life Science challenges that norm with this bold investment. Consequently, the company positions itself as a pioneer not just in India, but globally.
Key Features of the Ludhiana Plant
Design, Automation, and Quality Standards
The facility integrates robotics at every stage of production. This approach ensures that each product batch meets strict quality benchmarks. Additionally, automated systems reduce contamination risks that are common in manual setups. As a result, the plant can reliably serve both domestic and international buyers.
The location in Ludhiana offers strategic advantages as well. Punjab has strong logistics infrastructure and proximity to major raw material suppliers. Thus, the company benefits from both operational efficiency and supply chain reliability. In addition, the plant’s design complies with global Good Manufacturing Practice (GMP) standards. This compliance further strengthens the brand’s credibility in export markets.
Products and Target Consumer Base
Sports Nutrition for Every Athlete
Nutro Life Science specialises exclusively in sports nutrition and nutraceutical products. Its portfolio targets athletes, fitness enthusiasts, and performance-focused consumers. Specifically, the product range includes:
- Whey protein and plant-based protein
- Mass gainers and pre-workout supplements
- Amino acid supplements and fat burners
- Hydration solutions and ketogenic nutrition products
All products use high-quality raw materials sourced from rigorously vetted suppliers. This ensures consistency across every batch. Furthermore, the company develops its formulations to meet both domestic and international standards. The growing demand for clean-label, performance-based nutrition makes this portfolio highly relevant. Indeed, India’s fitness culture is booming, and this plant is built to serve that demand at scale.
Financial Goals and Growth Roadmap
Targeting Rs 500–600 Crore Valuation by FY28
Nutro Life Science has outlined an ambitious financial strategy alongside this facility launch. By the end of FY 2027–28, the company aims to achieve a valuation between Rs 500 crore and Rs 600 crore. Several key drivers will fuel this growth.
First, increased production capacity from the new plant will allow higher output volumes. Second, the company plans to expand aggressively into international markets. Third, stronger contract manufacturing partnerships will broaden its revenue base. Finally, automation-driven efficiency will reduce per-unit costs and improve margins.
Together, these strategies position Nutro Life Science for rapid and sustainable scale.
Why This Facility Matters for India
Raising the Bar for Nutraceutical Manufacturing
India’s nutraceutical industry is on an upward trajectory. Yet, many global buyers still question the consistency and hygiene standards of Indian-made products. This robotic facility directly addresses those concerns. By eliminating manual errors, Nutro Life Science builds a compelling case for India as a world-class nutraceutical exporter.
Additionally, the project signals growing investor confidence in Indian sports nutrition. As more consumers worldwide prioritise health and performance, demand for premium nutraceuticals will rise. Therefore, a facility of this scale and sophistication is not just timely — it is necessary.
In conclusion, Nutro Life Science’s robotic plant in Ludhiana sets a new benchmark for the Indian nutraceutical industry. It combines cutting-edge automation, a diverse product range, and a clear growth vision. The December 2026 launch will be one to watch closely.
